GMCH-32 department performs high-risk angioplasty

Tribune News Service

Updated At : 11:47 AM Jan 17, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Chandigarh, January 16

The Department of Cardiology at the GMCH-32 here has performed a complex and high-risk (CHIP) OCT-guided angioplasty of highly calcified left main bifurcation.

Dr Sreenivas Reddy said this angioplasty was performed on a 67-year-old person, who was hypertensive and diabetic and was having recurrent episodes of heart failure for the past one month.

Dr Jeet Ram Kashyap, Professor of Interventional Cardiology, discussed the option of performing this high-risk angioplasty with the support of Impella device.

Impella is the only non-surgical heart pump technology that has been approved by the USFDA as a safe and effective solution for a certain set of high-risk patients undergoing percutaneous coronary intervention (angioplasty). —

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles